Clinical trial

A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes

NCT00351546

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-02-01

PhasePHASE3

Study timeline

Study start (unknown)2005-02-01Date precision: month

Registry last updated2012-05-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

VildagliptinDRUG

Sponsors & collaborators

Novartislead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00351546 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.